As another trading week kicks off this morning, it would be a good time for investors to consider keeping an eye on the stocks of those companies that may have been in focus among investors last Friday. One of the companies that could be worth tracking this morning is Pacific Software Inc. (OTC: PFSF), which made a key announcement last Friday. The company announced that it had been successful in completing the acquisition of a science-backed dietary supplement that aided memory function and brain health.
The supplement had been sold profitably for over 8 years under the brand names A L Z Defense and SuppleMEM AD. The supplement also featured a formula that had been tested thoroughly by some of the leading researchers in the Alzheimer’s niche. The Chief Executive Officer of Pacific Software, Harrysen Mittler, spoke about the move as well. He stated that the acquisition of an established product would not only boost the company’s journey towards profitability but also mark a notable expansion in the strategic scope of Pacific Software. In the past, the company had only been interested in wound healing and skin care.
In the news release, the company also announced that the basic formula in the A L Z Defense product was an amalgamation of natural and safe products into one’medical food cocktail’ meant to support some of the vital components of memory, like neuroplasticity. It was also revealed that the formula had also been tested in two big multi-year lab experiments that had been financed by the NIH (National Institutes of Health). The first of those studies had been conducted at the University of California, Irvine, and had been conducted in a mouse model of Alzheimer’s. The formula was tested on dogs in the second study that took place at the University of Kentucky.